BACKGROUND Self-management (SM) support for patients with chronic obstructive pulmonary
disease (COPD) is variable in its coverage, content, method and timing of delivery. There …

Purpose This systematic review aimed to identify the most effective components of
interventions to facilitate self-management of health care behaviors for patients with COPD. …

… A continuum of support is now recognized which should ideally be personalized to reflect
an individual patient’s needs, including disease severity and other co-morbidities. Citation9,…

Background FMS-like tyrosine kinase 3 (FLT3) is the most frequent mutation in AML. With two
FLT3 inhibitors recently approved by the FDA (midostaurin and gilteritinib), there is a need …

… credit to the original author(s) and the source, provide a … ’s Creative Commons license,
unless indicated otherwise in a credit line to the material. If material is not included in the article’s …

Background Central nervous system (CNS) tumours account for around 25% of childhood
neoplasms. With multi-modal therapy, 5-year survival is at around 75% in the UK. …

In this article the reference numbers 60–68 and their citations were incorrect, and number
69 was missing in the References. As a result, publications were cited in the wrong places. …

Background: COPD self-management (SM) reduces hospital admissions and improves health
related quality of life (HRQoL). However, most SM trials have identified participants from …

Methods This section provides a detailed description of the economic model that was
developed and used to evaluate the cost-effectiveness (cost–utility) of self-management (SM) …

Introduction and objectives Guidelines recommend that COPD patients admitted to hospital
with an exacerbation should be assessed and considered for supported self-management …